ResearcherChinese PLA General HospitalActive in the last 2 years
Shasha Guan
Matched on ORCID iD 0009-0000-2873-1073; OpenAlex author ID A5048930482. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers · 2023: 2 papers · 2024: 1 paper
Papers 6
- High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospect… Co-author DOI 10.1186/s12967-024-04989-z↗
- Gene signature developed for predicting early relapse and survival in early-stage pancreatic cancer. Co-author DOI 10.1093/bjsopen/zrad031↗
- [Heterogeneity analysis of pancreatic cancer and identification of molecular subtypes of tumor cells based on CEACAM5, LGALS1 and CENPF gene expression]. Co-author DOI 10.12122/j.issn.1673-4254.2023.09.14↗
- S-1 Maintenance Therapy After First-Line Treatment With Nab-Paclitaxel Plus S-1 for Advanced Pancreatic Adenocarcinoma: A Real-World Study. Co-author DOI 10.3389/fonc.2022.865404↗
- Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma. Co-author DOI 10.3389/fonc.2022.926260↗
- Preoperative CA19-9 levels predict disease-free survival and overall survival in pancreatic adenocarcinoma patients after resection. Co-author DOI 10.21037/tcr.2019.04.24↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Quanli Han · 5 shared papers, 2019–2024 · strength 0.80
- Paper High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to firs… DOI 10.1186/s12967-024-04989-z↗
- Paper Gene signature developed for predicting early relapse and survival in early-stage pancreatic cancer. DOI 10.1093/bjsopen/zrad031↗
- Paper S-1 Maintenance Therapy After First-Line Treatment With Nab-Paclitaxel Plus S-1 for Advanced Pancreatic Adenocarcinoma:… DOI 10.3389/fonc.2022.865404↗
- Guanghai Dai · 5 shared papers, 2019–2024 · strength 0.80
- Paper High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to firs… DOI 10.1186/s12967-024-04989-z↗
- Paper Gene signature developed for predicting early relapse and survival in early-stage pancreatic cancer. DOI 10.1093/bjsopen/zrad031↗
- Paper S-1 Maintenance Therapy After First-Line Treatment With Nab-Paclitaxel Plus S-1 for Advanced Pancreatic Adenocarcinoma:… DOI 10.3389/fonc.2022.865404↗
- Lei Huang · 3 shared papers, 2022–2024 · strength 0.54
- Paper High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to firs… DOI 10.1186/s12967-024-04989-z↗
- Paper Gene signature developed for predicting early relapse and survival in early-stage pancreatic cancer. DOI 10.1093/bjsopen/zrad031↗
- Paper S-1 Maintenance Therapy After First-Line Treatment With Nab-Paclitaxel Plus S-1 for Advanced Pancreatic Adenocarcinoma:… DOI 10.3389/fonc.2022.865404↗
- Yan Xia Shi · 2 shared papers, 2022–2023 · strength 0.32
- Jianhe Sun · 1 shared paper, 2023 · strength 0.26
- Shuzhen Liu · 1 shared paper, 2023 · strength 0.26
- Guochao Deng · 2 shared papers, 2019–2022 · strength 0.26
- Yan Shi · 1 shared paper, 2024 · strength 0.22
- Liangchao Zhao · 1 shared paper, 2023 · strength 0.17
- Jie Li · 1 shared paper, 2022 · strength 0.15
- Yang Chen · 1 shared paper, 2019 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.